Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

PFE stock news

This page provides real-time market news, earnings updates, and company announcements related to Pfizer, Inc. (PFE).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-02-26 17:39 EST

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock? image

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

Finviz2026-02-17 16:33:40
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease image

Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

Finviz2026-02-19 11:03:48
Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders image

Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders

101 finance2026-02-19 11:06:40
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform image

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform

Finviz2026-02-19 12:03:42
Where is Pfizer Inc. (PFE) Headed? image

Where is Pfizer Inc. (PFE) Headed?

Finviz2026-02-19 14:54:43
Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial image

Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial

Finviz2026-02-20 08:39:45
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings? image

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

Finviz2026-02-23 16:48:49
Barclays Initiates Bristol Myers (BMY) with Overweight Rating on Pipeline Potential image

Barclays Initiates Bristol Myers (BMY) with Overweight Rating on Pipeline Potential

Finviz2026-02-23 18:15:41
BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 image

BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026

Finviz2026-02-24 11:48:47
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update image

Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Finviz2026-02-24 12:03:58
What's Going On With Kyntra Bio Stock Tuesday? image

What's Going On With Kyntra Bio Stock Tuesday?

Finviz2026-02-24 13:27:44
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory image

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Finviz2026-02-24 15:21:01
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory image

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Finviz2026-02-24 15:21:01
Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology? image

Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology?

101 finance2026-02-25 14:57:58
Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment image

Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment

Finviz2026-02-25 18:24:03
Pfizer Drops to 137th Place in Market Activity as Patent Expirations and Falling Revenue Impact Performance image

Pfizer Drops to 137th Place in Market Activity as Patent Expirations and Falling Revenue Impact Performance

101 finance2026-02-25 23:06:45
Moderna's Stock Up 1.68% as FDA Revises mRNA-1010 Approval Path Trading at 334th Volume Rank image

Moderna's Stock Up 1.68% as FDA Revises mRNA-1010 Approval Path Trading at 334th Volume Rank

101 finance2026-02-26 00:04:02
Moderna's Stock Up 1.68% as FDA Revises mRNA-1010 Approval Path Trading at 334th Volume Rank image

Moderna's Stock Up 1.68% as FDA Revises mRNA-1010 Approval Path Trading at 334th Volume Rank

101 finance2026-02-26 00:04:02
RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds image

RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds

Finviz2026-02-26 02:51:37
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results image

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results

Finviz2026-02-26 21:09:42

PFE stock chart

PFE stock details

PFE stock price change

On the last trading day, PFE stock closed at 27.09 USD, with a price change of -0.18% for the day.

Trade stock perps

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
PFE stock news